LiveMedBench: Realistic Clinical Benchmarking

• LiveMedBench is a conceptual benchmarking framework that models clinical AI evaluation through realistic workflows such as chart review, diagnosis, and treatment planning.
• It emphasizes key characteristics like personalization, interactivity, sequential decision-making, and temporal reasoning to assess multi-agent clinical systems.
• Evaluation metrics under this paradigm span diagnostic accuracy, retrieval fidelity, clinician validation, and operational latency, moving beyond static medical QA.

LiveMedBench is not explicitly defined in the provided sources, and no paper in the supplied corpus introduces a benchmark with that name. Within this literature, however, closely related work converges on a recognizable problem setting: evaluation of clinical AI systems under realistic conditions characterized by personalization, interactivity, sequential decision-making, multimodal evidence integration, heterogeneous electronic health records, temporal reasoning, clinician validation, and operational constraints. In that narrower sense, “LiveMedBench” can only be understood here as an inferred label for the class of clinically realistic benchmarking paradigms represented by MedChain, EHRNavigator’s institutional chart-review setting, and interactive simulation frameworks such as MedAgentSim (Liu et al., 2024).

1. Definition status and scope

The supplied sources do not contain a direct definition of LiveMedBench, nor do they attribute that term to a specific dataset, benchmark suite, or evaluation protocol. The closest available material consists of benchmark-centric and deployment-oriented frameworks that were explicitly designed to move beyond static medical question answering and licensing-exam evaluation. These works argue that realistic clinical evaluation must stress properties that ordinary benchmark design often omits, especially personalization, interactivity, sequentiality, schema heterogeneity, temporal anchoring, multimodal evidence fusion, and clinician-grounded validation (Liu et al., 2024).

This suggests that any encyclopedia treatment of LiveMedBench, based strictly on the available evidence, must proceed indirectly. Rather than describing a named benchmark, it must reconstruct the benchmark class that these papers instantiate. A plausible implication is that LiveMedBench, if used as a label in adjacent discourse, would denote not a single dataset but a benchmarking philosophy: evaluating clinical agents in workflows that resemble chart review, consultation, diagnosis, and treatment planning more closely than one-shot QA.

2. Benchmark realism: personalization, interactivity, and sequentiality

Among the supplied sources, MedChain gives the most explicit formulation of realistic clinical benchmarking. It introduces a dataset of 12,163 clinical cases covering five key stages of clinical workflow: Specialty Referral, History-taking, Examination, Diagnosis, and Treatment. The benchmark distinguishes itself by three properties of real-world clinical practice: personalization, interactivity, and sequentiality. At the beginning, the agent sees only the chief complaint and basic patient information; additional patient-specific detail emerges through interaction and through the outputs of prior stages. Interactivity is operationalized through a local Gemma 2 (9B) patient agent that responds to questions without access to the true diagnosis. Sequentiality is enforced because each stage’s output becomes the next stage’s input, making error propagation an explicit part of evaluation rather than a hidden artifact (Liu et al., 2024).

This design materially changes what is being measured. A system is no longer rewarded only for producing a plausible final answer; it must also decide what to ask, what to examine, and how to preserve coherence across handoffs. The benchmark’s scale is also notable: it spans 19 medical specialties, 156 sub-categories, and 7,338 medical images with corresponding reports, and its quality control involved random review of 6,000 cases, with 94.7% meeting the quality threshold and Cohen’s kappa = 0.82. These details position MedChain as a prototype for what a live-clinical benchmark looks like when realism, not just difficulty, is the organizing principle (Liu et al., 2024).

A related dynamic-diagnosis formulation appears in the consultation-flow framework built on the MVME benchmark. There the task is cast as a partially observable process with a Doctor agent, Patient agent, and Examiner agent, and the consultation is explicitly split into Inquiry, Examination, and Diagnosis phases. The paper’s central concern is premature closure: foundation models tend to diagnose too early, with insufficient persistence in information collection. Its hierarchical action set and RL-guided consultation policy therefore evaluate not just diagnostic correctness but whether the agent follows a clinically plausible information-gathering trajectory (Wang et al., 19 Mar 2025).

3. Institutional and chart-review evaluation

A second strand of benchmark design in the supplied corpus emphasizes real-world deployment conditions rather than synthetic workflow simulation. EHRNavigator is the clearest example. It formulates patient-level clinical question answering as $A = f(q, T, N)$, where $q$ is the question, $T$ the structured tables, and $N$ the unstructured notes, and evaluates the system not only on public datasets but also on YNHHQA, a 100-question physician-curated patient-trajectory benchmark built on real hospital data under realistic conditions characterized by diverse schemas, temporal reasoning demands, and multimodal evidence integration. For this institutional evaluation, correctness is determined by chart review rather than string matching, and answers are judged within the pre-specified temporal window. On this benchmark, EHRNavigator achieved 86% overall accuracy, with 87.5% on laboratory trajectories, 80.0% on medication dosing/timing, and 95.0% on lab–medication relations, while maintaining clinically acceptable response times (Qian et al., 15 Jan 2026).

What distinguishes this evaluation regime is its operational grounding. The same system was tested across MIMIC-III relational structure and OMOP CDM at Yale New Haven Hospital, explicitly addressing schema heterogeneity rather than assuming a fixed institutional data model. The note-retrieval module is conditioned on structured evidence from SQL execution, and temporal reasoning is treated as a central failure point, with reported errors such as visit-scope mismatch, null-data situations, and cross-encounter drift. A plausible implication is that a benchmark deserving the label “live” must include such failure modes, because they arise from actual EHR topology and clinical workflow rather than from abstract reasoning alone (Qian et al., 15 Jan 2026).

This deployment-oriented conception differs from benchmark design centered on public test sets alone. It measures whether an agent can bridge benchmark evaluation and hospital use, not merely whether it scores highly on a static corpus. In that sense, chart-review accuracy, response latency, and recoverability under minimal clinician interaction are as important as conventional correctness metrics.

4. Interactive simulation as benchmark infrastructure

A third benchmark paradigm in the supplied sources is fully simulated but still designed to approximate live clinical reasoning. MedAgentSim describes an open-source simulated hospital environment with doctor, patient, and measurement agents in which the doctor begins with incomplete information, must ask the patient clarifying questions, selectively request examinations such as temperature, blood pressure, ECG, MRI, and X-ray from the measurement agent, and then reason toward a diagnosis. The simulation has a Conversation Phase and an Experience Replay Phase, and it introduces self-improvement through multi-agent discussion, chain-of-thought reasoning, and experience-based knowledge retrieval. The framework is evaluated on NEJM, MedQA, and MIMIC-IV, plus NEJM Extended and MedQA Extended, after converting originally static QA data into interactive simulations (Almansoori et al., 28 Mar 2025).

The reported numbers illustrate how strongly benchmark behavior depends on interaction structure. MedAgentSim reaches 26.7% on NEJM, 28.3% on NEJM Extended, 70.8% on MedQA, 72.0% on MedQA Extended, and 79.5% on MIMIC-IV, outperforming the cited baseline Multi-Agent Clinic across all benchmarks. Its ablation shows additive gains from Measurement, Memory, Chain-of-thought, and Ensembling. For LLaMA 3.3 70B, the progression is 54.7% baseline, 59.4% with Measurement, 65.1% with Memory, 68.9% with CoT, and 70.8% with Ensembling. These results do not merely indicate a stronger model; they show that benchmark construction itself—partial observability, test-ordering, and memory of prior cases—changes the capabilities being measured (Almansoori et al., 28 Mar 2025).

This suggests that “live” benchmarking can be simulated without being trivialized, provided the simulation preserves uncertainty, selective evidence acquisition, and evolving case state. The patient and measurement agents act as information gates, forcing the model to curate its own evidence stream instead of consuming a fully assembled chart.

5. Evaluation metrics and operational criteria

The supplied literature collectively broadens the metric vocabulary that would be relevant to any LiveMedBench-like construct. MedChain uses Accuracy for single-label tasks, IoU for multi-label or key-point overlap tasks such as referral Level 2, history-taking, and treatment, DocLens claim recall for examination report generation, and a five-level grading system for diagnosis. Its proposed MedChain-Agent achieved the best average score of 0.5269, with stage-level results of 0.5873 for Specialty Referral Level 1, 0.3505 for Specialty Referral Level 2, 0.5836 for History-taking, 0.6566 for Examination, 0.5218 for Diagnosis, and 0.4613 for Treatment (Liu et al., 2024).

EHRNavigator adds another layer of evaluation: Accuracy for entity-focused and SQL-answerable tasks, ROUGE-L, BERTScore, and BARTScore for free-text note QA, Chart-review accuracy for institutional evaluation, and Latency for operational feasibility. On YNHHQA, the median end-to-end latency is reported as 11.53 s for lab questions, 15.47 s for drug dosing/timing, 17.95 s for lab–drug combination questions, with an overall median of 12.16 seconds. Manual review of 100 DrugEHRQA cases located 5 errors in structured querying, 3 in unstructured retrieval, and 6 in final synthesis, while YNHHQA failure analysis found 57.1% visit/encounter misalignment, 21.4% information displacement in semi-structured fields, and smaller fractions for fragmented synthesis, information overflow, and pure reasoning hallucination (Qian et al., 15 Jan 2026).

These evaluation schemes indicate that clinically realistic benchmarking is irreducibly multidimensional. A system can be benchmarked on final correctness, but also on retrieval fidelity, synthesis fidelity, temporal anchoring, response time, and recoverability. The supplied corpus therefore implies that a benchmark modeled on live clinical use cannot be reduced to a single accuracy number without discarding the properties that make it clinically meaningful.

6. Relation to multi-agent clinical systems

The benchmark logic reconstructed here is tightly coupled to the rise of multi-agent clinical architectures. Several supplied papers explicitly argue that monolithic models struggle with context dilution, hallucination, weak conflict handling, or brittle one-shot reasoning, and they therefore decompose clinical tasks into specialist sub-processes. In GI oncology, a hierarchical MDT-like architecture with Text, Endoscopy, Radiology, Laboratory, and MDT-Core agents achieved a composite expert evaluation score of 4.60/5.00 versus 3.76/5.00 for a monolithic baseline, with especially strong gains in reasoning logic and medical accuracy. The same paper reports explicit cross-modal conflict detection, including a “Staging Discrepancy Detected” warning when $|T_{endo}-T_{rad}|>1$, and claims latency under one minute per case through parallel specialist execution (Zhang et al., 9 Dec 2025).

This matters for benchmark design because multi-agent systems demand evaluation that can expose coordination quality, not merely final answers. MedChain’s feedback mechanism exists largely to control error propagation across stages. EHRNavigator’s decomposition into structured query, note retrieval, and synthesis makes it possible to localize failure to a module. MedAgentSim’s experience replay phase measures whether the system improves through reflection. A plausible implication is that LiveMedBench, if conceived as a modern clinical benchmark, would be especially relevant to multi-agent systems because they rely on precisely the workflow granularity that static medical QA benchmarks conceal.

The same point appears in frameworks focused on verification and reliability. Hybrid-Code, for example, argues that reliability through redundancy is more valuable than pure model performance in production healthcare systems and evaluates a Coder plus Auditor pipeline locally on 1,000 MIMIC-III discharge summaries, reporting 0% hallucination rate among accepted codes within a 257-code knowledge base, 24.47% verification rate, 34.11% coverage, and 0.49 seconds per case runtime. Although it is not a benchmark paper, it exemplifies the kind of production-oriented reliability target that a live benchmark would need to measure (Yu, 26 Dec 2025).

7. Limits of the reconstructed concept

Because no source in the supplied corpus explicitly defines LiveMedBench, any positive description remains inferential. The safest conclusion is therefore negative but informative: the available evidence supports a family resemblance among realistic clinical benchmarks, not the existence of a single canonical benchmark with that name. MedChain contributes sequential, interactive, patient-specific workflow evaluation; EHRNavigator contributes physician-curated chart-review evaluation under heterogeneous real-hospital schemas; MedAgentSim contributes partially observable interactive simulation with selective testing and memory; and consultation-flow work on MVME contributes dynamic diagnosis under explicit phase structure (Liu et al., 2024).

This suggests that “LiveMedBench” would be most coherently understood as a shorthand for benchmarking regimes that combine several properties at once: patient-level realism, staged clinical workflow, active information acquisition, multimodal evidence, temporal sensitivity, module-level error analysis, clinician validation, and operational latency measurement. What the supplied literature does not justify is a more specific claim about its dataset composition, exact tasks, metric set, or authorship. Those details are absent.

In that constrained sense, LiveMedBench belongs less to a named artifact than to a methodological transition in clinical AI evaluation: from static exam-style testing toward evaluation embedded in the actual structure of clinical work.